| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |